GW-501516 (Cardarine) Capsules

GW-501516 (Cardarine) Capsules contain a potent synthetic agonist of the peroxisome proliferator-activated receptor delta (PPARδ). Originally developed for the treatment of metabolic and cardiovascular conditions such as dyslipidemia, obesity, and type 2 diabetes, Cardarine enhances fat-burning capacity by shifting the body’s energy utilization from glucose to lipids. It promotes increased endurance, improved lipid profiles, and muscle metabolism. These capsules are intended strictly for scientific research and analytical purposes and are not for human consumption.

Pharmacology and Mechanism of Action

GW-501516 is a selective PPARδ agonist that activates genes involved in fatty acid oxidation and energy metabolism. By increasing lipid utilization in skeletal muscle and other tissues, it enhances endurance and metabolic efficiency. It has been shown to improve HDL cholesterol levels, reduce triglycerides, and positively affect insulin sensitivity. While it demonstrated promising effects in preclinical and early clinical studies, concerns about carcinogenicity in animal models have limited its therapeutic development.

Intended Use

GW-501516 Capsules are intended strictly for laboratory research, including pharmacological, metabolic, and toxicological studies related to PPARδ activation, lipid metabolism, and exercise physiology. They are not for human consumption or clinical use.

Packaging & Shipping

The capsules are securely packaged and shipped discreetly with tracking. Typical delivery times range from 24 to 72 hours within the USA and up to 5 days internationally, depending on destination. Shipping fees are calculated at checkout based on location.

Legal & Compliance Disclaimer

All products are sold for research purposes only and are not intended for human consumption. Customers must verify the legal status of GW-501516 (Cardarine) in their jurisdiction before ordering. The vendor reserves the right to accept or decline orders based on intended use.